You are here

Amgen

One Drug, Two Names, Two Wildly Different Prospects

Motley Fool

Sat, 11/20/10 - 12:22 pm

Exclusive Picks From Street’s Top Biotech Analyst

CNBC

Sat, 11/20/10 - 12:15 pm

Human Genome Sciences

United Therapeutics

Amgen's Bone Drug Denosumab Cleared to Treat Fractures in Cancer Patients

Bloomberg

Sat, 11/20/10 - 12:10 pm

Amgen's Xgeva Approved

Yahoo/Zacks.com

Fri, 11/19/10 - 11:16 am

Actelion, Eyed by Amgen, May Fetch $9.8 Billion in Takeover, Analysts Say

Bloomberg

Thu, 11/18/10 - 07:58 am

Actelion shares surge (again) as M&A buzz hits fever pitch

Fierce Biotech

Wed, 11/17/10 - 11:46 am

Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards

Bradenton Herald, FL

Sat, 11/6/10 - 01:25 pm

[video]Amgen in Focus

Yahoo/CNBC

Wed, 11/3/10 - 07:00 pm

healthcare reform

Time to Sell Amgen?

Motley Fool

Wed, 11/3/10 - 06:57 am

Amgen proposes key hurdles for biosimilar regs

Fierce Biotech

Tue, 11/2/10 - 11:27 am

Biotech Calendar: Key Dates for November

TheStreet.com

Fri, 10/29/10 - 12:11 pm

Gilead Sciences

Bristol-Myers Squibb

Cadence Pharmaceuticals

Human Genome Sciences

Amgen's Bone Drug Prolia Gets Final Approval From U.K. Health-Cost Agency

Bloomberg

Wed, 10/27/10 - 11:50 am

Thank Goodness for Amgen's New Kids

Motley Fool

Tue, 10/26/10 - 03:20 pm

Amgen Case Shows How to Hide Bad Drug Data and Get Away With It

BNET Pharma

Mon, 10/25/10 - 08:14 pm

Amgen Beats Estimates With Shrinking Profit, Sales

Bloomberg

Mon, 10/25/10 - 05:19 pm

Ahead of the Bell: Amgen to report 3Q after bell

Yahoo/AP

Mon, 10/25/10 - 09:27 am

7 Big Pharma Stocks Near 52-Week Lows

Motley Fool

Sat, 10/23/10 - 12:44 pm

Teva Pharmaceuticals

7 Big Pharma Stocks Near 52-Week Lows

Motley Fool

Sat, 10/23/10 - 11:16 am

Teva Pharmaceuticals

Amgen's Anemia Drug Aranesp Is Safe Before Kidney Dialysis, FDA Panel Says

Bloomberg

Tue, 10/19/10 - 10:34 am

Promising Data on Amgen Drug

Yahoo/Zacks

Sat, 10/16/10 - 09:08 am

Pages